Patent details

EP2836508 Title: INSULIN FORMULATIONS

Basic Information

Publication number:
EP2836508
PCT Application Number:
PCT/EP/2013/057196
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137143038
PCT Publication Number:
WO/2013/153000
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INSULIN FORMULATIONS
French Title of Invention:
FORMULATIONS À BASE D'INSULINE
German Title of Invention:
INSULINFORMULIERUNGEN
SPC Number:

Dates

Filing date:
05/04/2013
Grant date:
29/06/2016
EP Publication Date:
29/06/2016
PCT Publication Date:
17/10/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/02/2015
EP B1 Publication Date:
29/06/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/04/2017
Expiration date:
05/04/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/04/2013
 
 

Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:
STEENSGAARD Dorte Bjerre
Address:
Denmark (DK)

2

Name:
NAVER Helle
Address:
Denmark (DK)

3

Name:
PETTERSON Ingrid Vivika
Address:
Denmark (DK)

4

Name:
SCHLEIN Morten
Address:
Denmark (DK)

Priority

1

Priority Number:
12163730
Priority Date:
11/04/2012
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
201261624463
Priority Date:
16/04/2012
Priority Country:
United States (US)

3

Priority Number:
13157748
Priority Date:
05/03/2013
Priority Country:
European Patent Office (EPO) (EP)

4

Priority Number:
201361778554
Priority Date:
13/03/2013
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 47/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages